Marc S. Sabatine

2019 ESC/EAS Guidelines for the management of dyslipidaemias: <i>lipid modification to reduce cardiovascular risk</i>

François Mach, Colin Baigent, Alberico L. Catapano et al. · European Heart Journal · 2019 · 8.4K citations · Full text

Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction

John J.V. McMurray, Scott D. Solomon, Silvio E. Inzucchi et al. · New England Journal of Medicine · 2019 · 6.4K citations · Full text

Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes

Stephen D. Wiviott, Itamar Raz, Marc P. Bonaca et al. · New England Journal of Medicine · 2018 · 6K citations · Full text

2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes

Ezra A. Amsterdam, Nanette K. Wenger, Ralph G. Brindis et al. · Journal of the American College of Cardiology · 2014 · 3.6K citations

Percutaneous Coronary Intervention, Cardiovascular Disease, Health Policy +12

Cytochrome P-450 Polymorphisms and Response to Clopidogrel

Jessica L. Mega, Sandra Close, Stephen D. Wiviott et al. · New England Journal of Medicine · 2008 · 2.4K citations · Full text